For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.
Clinical Trial Evidence for Wegovy Wegovy approval was supported by large, randomized clinical trials, including the STEP 1 study: 1,961 adults with obesity or overweight plus weight-related health conditions 68-week study duration Average weight loss of approximately 14.9% of body weight 86% of participants lost at least 5% of body weight 69% lost at least 10% 50% lost at least 15% Participants followed reduced-calorie diets and increased physical activity Before receiving FDA approval, GLP-1 medications completed Phase I, Phase II, and Phase III trials
diversity, equity, and inclusion
Chef Zigga showcases what they call "Trilogy" a combination of flaxseeds, hemp, and chia seeds
Start with a personalized online consultation with our healthcare professional who will draft a treatment plan tailored to your health objectives